((4S,5R)-2-(4-(tert-Butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl)(4-(3-(methylsulfonyl)p ropyl)piperazin-1-yl)methanone
CAS: 939981-39-2
Ref. 3D-PMB98139
| 1mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado |
Informação sobre produto
Nome:
((4S,5R)-2-(4-(tert-Butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl)(4-(3-(methylsulfonyl)p ropyl)piperazin-1-yl)methanone
Descrição:
(4S,5R)-2-(4-(tert-Butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl)(4-(3-(methylsulfonyl)prop yl)piperazin-1-yl)methanone (TPI) is a synthetic compound that has been shown to have potent cytotoxicity against cancer cells in vitro. TPI targets protein-protein interactions and is currently being investigated for its potential as a cancer therapy. It has also been shown to be effective in the treatment of skin cancers in mouse models. TPI has not yet been tested on humans and there are no clinical data available.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
727.79 g/mol
Fórmula:
C38H48Cl2N4O4S
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
